CMIC Holdings Co Ltd
TSE:2309

Watchlist Manager
CMIC Holdings Co Ltd Logo
CMIC Holdings Co Ltd
TSE:2309
Watchlist
Price: 999 999.9999 JPY 37 893.92%
Market Cap: 47.6B JPY
Have any thoughts about
CMIC Holdings Co Ltd?
Write Note

CMIC Holdings Co Ltd
Non-Reccuring Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CMIC Holdings Co Ltd
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
CMIC Holdings Co Ltd
TSE:2309
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Chiome Bioscience Inc
TSE:4583
Non-Reccuring Items
ÂĄ2.3m
CAGR 3-Years
-44%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Medinet Co Ltd
TSE:2370
Non-Reccuring Items
-ÂĄ10.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
34%
CellSource Co Ltd
TSE:4880
Non-Reccuring Items
ÂĄ8.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Linical Co Ltd
TSE:2183
Non-Reccuring Items
-ÂĄ23.4m
CAGR 3-Years
57%
CAGR 5-Years
32%
CAGR 10-Years
-50%
WDB coco Co Ltd
TSE:7079
Non-Reccuring Items
-ÂĄ212k
CAGR 3-Years
N/A
CAGR 5-Years
-192%
CAGR 10-Years
N/A
No Stocks Found

CMIC Holdings Co Ltd
Glance View

Market Cap
47.6B JPY
Industry
Life Sciences Tools & Services

CMIC Holdings Co., Ltd. engages in the provision of support services for pharmaceutical development, manufacturing, and sales. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 5,569 full-time employees. The company went IPO on 2004-06-18. The Contract Research Organization (CRO) segment offers monitoring, data management, pharmaceutical consulting and nonclinical services. The Contract Manufacturing Organization (CMO) segment is engaged in the entrusted manufacture of drugs for pharmaceutical companies. The Contract Sales Organization (CSO) segment is engaged in the operation and marketing support for medicinal products. The Health Care segment conducts site support institute (SMO) business, and provides health care information services. The Intellectual Property Development (IPD) segment develops and sells diagnostic products and orphan drugs.

Intrinsic Value
1 112 435.4753 JPY
Undervaluation 10%
Intrinsic Value
Price

See Also

Back to Top